Cambridge Healthtech Institute’s 12th International

Leaders in Biobanking Congress

Innovations to Maintain Integrity and Maximize Investment in Biospecimens

September 16-18, 2020

The availability of quality data and samples is the foundation of all research. In precision medicine, biobanks play a key role in the overall success of research infrastructure. One common challenge in building this infrastructure is the ability to capture, combine, and curate multiple data sources tied to biosamples. The role of honest broker, the navigation of industry partnerships, and the increased complexity of biospecimen requests – in terms of sample type and associated clinical variables, plus molecular and multidimensional longitudinal data – have all created new challenges for supplying the biobanking needs of the future. 

Cambridge Healthtech Institute’s 12th International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. The event features efforts in large-scale sample de-identification, data integration, and digital pathology. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.

Innovations covered include:

We encourage the following professionals to submit a title and summary of their experiences to be considered for a presentation:

• Molecular researchers utilizing biospecimens for their research
• Biobankers providing biospecimens, developing biopreservation technologies standards and protocols, and managing resources while navigating regulatory compliance
• R&D researchers and clinical trial professionals collecting, analyzing, and utilizing data

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is March 6, 2020.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com

For partnering and sponsorship information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com